CUSIP 45720N103COMINBXQ4 2025
12 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Perceptive Advisors LLC | 1.45M | $114.76M |
| 2 | Viking Global Investors LP | 1.44M | $113.58M |
| 3 | Morgan Stanley | 1.17M | $92.25M |
| 4 | Sanofi | 1.16M | $91.48M |
| 5 | Hightower Advisors, LLC | 870.5K | $68.77M |
| 6 | Blackrock, Inc. | 777.4K | $61.41M |
| 7 | Vanguard Group Inc | 623.1K | $49.22M |
| 8 | Sofinnova Investments, Inc. | 454.7K | $35.92M |
| 9 | Capital Research Global Investors |
| 4 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 4.7% | 680.4K | SEC |
| 5 | Feb 26, 2025 | The Jon F. Kayyem And Paige Gates-Kayyem Family Trust | 13D/A | 7.9% | — | SEC |
| 6 | Feb 26, 2025 | Mark Lappe | 13D/A | 6.4% | — | SEC |
| 7 | Feb 4, 2025 | Blackrock, Inc. | 13G | 5.7% | 831.8K | SEC |
| 8 | Nov 14, 2024 | Perceptive Advisors LLC | 13G | 9.9% | 1.49M | SEC |
| 9 | Jun 7, 2024 | Viking Global Investors LP | 13G | 12.3% | 1.79M | SEC |
| 10 | Jun 3, 2024 | Kayyem Jon Faiz | 13D | 5.6% | 806.1K | SEC |
See the full Schedule 13D/13G history for Inhibrx Biosciences Inc.
Unlock full history| 421.6K |
| $33.30M |
| 10 | State Street Corp | 375.0K | $29.62M |